For the Inventor, By the Inventor

Enter assignee name

County Cork, Ireland

Janssen Sciences Ireland Uc

USPTO Granted Patents = 111

CIPO Patents = 243

EPO Patents = 64

Trademarks = 6

Forward Citations = 538

Loading Chart...

Loading Chart...

448 inventors (with patents filed for the assignee):

Pierre Jean-Marie Bernard Raboisson (71 out of 178 patents)

Tim Hugo Maria Jonckers (35 out of 77 patents)

Abdellah Tahri (24 out of 61 patents)

4. David Craig McGowan (23 out of 61 patents)

5. Stefaan Julien Last (23 out of 37 patents)

6. Koen Vandyck (21 out of 44 patents)

7. Sandrine Marie Helene Vendeville (19 out of 41 patents)

8. Lili Hu (18 out of 37 patents)

9. Magali Madeleine Simone Motte (15 out of 25 patents)

10. Samuël Dominique Demin (13 out of 16 patents)

11. Ludwig Paul Cooymans (12 out of 25 patents)

12. Anil Koul (12 out of 31 patents)

13. Werner Embrechts (12 out of 18 patents)

14. Wendy Mia Albert Balemans (12 out of 19 patents)

15. Jerôme Emile Georges Guillemont (12 out of 27 patents)

Core Competencies:

Darunavir Formulations

Pyrimidine Derivatives

Heterocyclic Compounds

Antibacterial Compounds

Hepatitis B Treatments

HIV Inhibitors

Respiratory Syncytial Virus

Functionalized Pentanoic Acids

Polyinosinic-Polycytidylic Acid

Macrocyclic Purines

Piperidine Derivatives

Indoles

111 patents: Sort by Forward Citations

1. 12011506 - Combination and uses and treatments thereof (2024-06-18),

2. 11654150 - Darunavir combination formulations (2023-05-23),

3. 11541050 - Pyrimidine derivatives for the treatment of viral infections (2023-01-03),

4. 11180472 - Antibacterial compounds (2021-11-23),

5. 11179396 - Heterocyclic compounds as antibacterials (2021-11-23),

6. 11078193 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2021-08-03),

7. 10995064 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2021-05-04),

8. 10941113 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2021-03-09),

9. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B (2020-12-29),

10. 10857102 - Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate (2020-12-08),

11. 10786518 - Compositions and methods of treating HIV (2020-09-29),

12. 10780089 - Pyrimidine derivatives for the treatment of viral infections (2020-09-22),

13. 10676429 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B (2020-06-09),

14. 10626108 - Heterocyclic indoles for use in influenza virus infection (2020-04-21),

15. 10611755 - Aryl substituted pyrimidines for use in influenza virus infection (2020-04-07),

Janssen Sciences Ireland Uc is a leading pharmaceutical company in Ireland, dedicated to improving patients' lives through innovative medicines and therapeutic solutions. As a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, they focus on developing and delivering transformative healthcare solutions in the areas of immunology, oncology, neuroscience, infectious diseases, and more. Janssen Sciences Ireland Uc is committed to addressing unmet medical needs and fostering collaboration to advance healthcare outcomes globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

111 Patents

#1 in County Cork

#25 in Ireland

#6,897 in the World

County Cork, Ireland

Janssen Sciences Ireland Uc

Forward Citations = 538

448 inventors:

Pierre Jean-Marie Bernard Raboisson (71 out of 178 patents)

Tim Hugo Maria Jonckers (35 out of 77 patents)

Abdellah Tahri (24 out of 61 patents)

4. David Craig McGowan (23 out of 61 patents)

5. Stefaan Julien Last (23 out of 37 patents)

Please report any incorrect information to support@idiyas.com

Loading…